NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $261,000 | -6.8% | 3,059 | +3.3% | 0.07% | -12.2% |
Q4 2020 | $280,000 | -33.0% | 2,960 | -38.4% | 0.08% | -41.4% |
Q3 2020 | $418,000 | -3.7% | 4,804 | -3.2% | 0.14% | -13.0% |
Q2 2020 | $434,000 | +3.6% | 4,964 | -2.3% | 0.16% | -13.9% |
Q1 2020 | $419,000 | +4.0% | 5,082 | +19.4% | 0.19% | +47.2% |
Q4 2019 | $403,000 | +13.5% | 4,256 | +4.3% | 0.13% | +8.5% |
Q3 2019 | $355,000 | -16.1% | 4,081 | -12.0% | 0.12% | -14.0% |
Q2 2019 | $423,000 | +7.4% | 4,635 | +13.2% | 0.14% | +4.6% |
Q1 2019 | $394,000 | +45.4% | 4,095 | +29.5% | 0.13% | +35.4% |
Q4 2018 | $271,000 | -78.9% | 3,162 | -81.7% | 0.10% | -79.7% |
Q1 2017 | $1,283,000 | +17.3% | 17,280 | +15.0% | 0.47% | +11.6% |
Q4 2016 | $1,094,000 | +119.2% | 15,022 | +137.6% | 0.42% | +116.9% |
Q3 2016 | $499,000 | -4.6% | 6,323 | -0.2% | 0.20% | -9.3% |
Q2 2016 | $523,000 | +15.7% | 6,333 | +1.5% | 0.22% | +6.4% |
Q1 2016 | $452,000 | -3.4% | 6,237 | +14.7% | 0.20% | -10.2% |
Q4 2015 | $468,000 | – | 5,436 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |